Nasal Chondrocytes Used to Repair Damaged Knee Joints

Share this content:
Nasal Chondrocytes Used to Repair Damaged Knee Joints
Nasal Chondrocytes Used to Repair Damaged Knee Joints

FRIDAY, Oct. 21, 2016 (HealthDay News) -- A new approach to the treatment of articular cartilage injuries has been developed and appears promising, according to a report published in the Oct. 22 issue of The Lancet.

Ivan Martin, Ph.D., a professor of tissue engineering at the University of Basel in Switzerland, and colleagues isolated chondrocytes from a 6 mm nasal septum biopsy specimen. The team then expanded and cultured the cells onto collagen membranes to engineer cartilage grafts. The engineered graft was used to replace damaged cartilage after it was surgically removed from the patient's knee. Ten patients with symptomatic, posttraumatic, full-thickness cartilage lesions on the femoral condyle or trochlea were treated.

Two years after the procedure, magnetic resonance imaging revealed that new tissue had developed that was similar to normal knee cartilage. In addition, nine patients reported improvements in the use of their knee and less pain. One patient was excluded because of several new sports injuries. No adverse reactions were reported, but two serious adverse events unrelated to the procedure occurred -- an independent injury in the untreated knee and new cartilage damage in other areas of the treated knee, the researchers said.

"Treatment of cartilage injuries remains a significant clinical problem, and there is no gold standard treatment and no optimal treatment available," Nicole Rotter, M.D., vice chair of the department of otorhinolaryngology at Ulm University in Germany, told HealthDay. Using cells from the nose for joint repair is completely new, added Rotter, who co-wrote an editorial accompanying the study. "Nasal cartilage might be a great source for cartilage repair; however, further clinical studies are required," she added.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »